Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05067868 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Replagal in Children and Adults With Fabry Disease in India

StatusRecruiting
PhasePhase 4
SponsorShire
Started2022-11-01
View on ClinicalTrials.gov ↗
The main aim of this study is to learn more about the safety profile of Replagal. Participants will receive Replagal every 2 weeks at the clinic for about 1 year.

Amendment history 2 changes detected by DataLookout

2026-09-04
Primary completion pushed: 2026-10-31 → 2027-10-31
2026-09-04
Completion pushed: 2026-11-30 → 2027-10-31
Trial Details
NCT Number NCT05067868
Lead Sponsor Shire
Collaborators: Takeda
Conditions Fabry Disease
Enrollment 5 participants
Start Date 2022-11-01
Primary Completion 2027-10-31 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-03